NIH Human Embryonic Stem Cell Registry

Detailed information for selected cell line:

Cell Line: Lis14_ Alport_3; Alport Syndrome mutation
NIH Registration Number: 0340
NIH Approval Number: NIHhESC-15-0340
Available for Distribution: Yes
Provider Restrictions: MTA and Tel Aviv Medical Center IRB amendment required

Additional Information: The embryo from which this hESC line was derived was affected with Alport Syndrome

NIH Restrictions: NIH-funded research with this line is limited to research on Alport Syndrome, consistent with the language from the informed consent document.

Submitting Organization: Tel Aviv Sourasky Medical Center
Provider Name: Dalit Ben-Yosef
Provider Phone:  
Provider Email: dalitb@tlvmc.gov.il
Provider URL: https://www.tasmc.org.il/sites/en/Research/Tech-Transfer/Stem-Cell-Research-laboratory/Pages/Stem-Cell-Research-laboratory.aspx
Approval Date: 07/16/2015


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on October 03, 2022 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster